All News

Biomarkers, Genetic Testing and More Make Way in GU Cancers

March 5th 2025, 2:00pm

Dr. Park shares the three biggest takeaways, in his opinion, to have come out of the ASCO GU Symposium, highlighting studies across kidney, bladder and prostate cancers.

Verzenio Combo May Improve Survival in HR+/HER2– Advanced Breast Cancer

March 4th 2025, 10:00pm

Verzenio plus Faslodex improved progression-free survival in HR+/HER2– advanced breast cancer after CDK/6i failure, with a manageable safety profile.

Better Understanding Genetic Mutations Influence in Cancer Care

March 4th 2025, 8:02pm

Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.

Breast Cancer And Depending On The Kindness Of Strangers

March 4th 2025, 6:00pm

I reflect on my unexpected bond with a neighbor during my breast cancer treatment, finding comfort in his company when I needed someone to talk to.

Enhertu Associated With Survival Increase in HER2+ Metastatic Gastric Cancer

March 4th 2025, 5:00pm

Enhertu improved overall survival versus chemotherapy in HER2-positive metastatic gastric cancer, prompting an interim analysis and potential regulatory approvals.

Checkpoint Inhibitor Therapy and ISRT Maintains Outcomes in Younger Patients With cHL

March 4th 2025, 4:00pm

Replacing transplant and chemo with CI-based therapy and ISRT maintains survival, reduces side effects in younger patients with classic Hodgkin lymphoma.

FDA Approves Tevimbra Plus Chemotherapy For Some With Esophageal Cancer

March 4th 2025, 1:39pm

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1.

Expert Explains Safety of Krazati Regimen For Treating Colorectal Cancer

March 3rd 2025, 10:00pm

Krazati plus Erbitux is well tolerated in KRAS G12C-mutant metastatic colorectal cancer, with manageable side effects and less immune suppression.

Immune Checkpoint Inhibitors For Cancer Associated With Psoriasis Risk

March 3rd 2025, 8:00pm

Researchers have discovered a strong association between the use of immune checkpoint inhibitors for cancer treatment and a risk of new onset psoriasis.

Primary Central Nervous System Lymphoma Patient and Care Partner Roundtable Hosted by the End Brain Cancer Initiative

March 3rd 2025, 6:33pm